Conformationally defined retinoic acid analogues. 4. Potential new agents for acute promyelocytic and juvenile myelomonocytic leukemias

Journal of Medicinal Chemistry

Volumn 41, Issue 10, 1998, Pages 1679-1687

  Muccio, Donald D ^a   Brouillette, Wayne J ^a   Breitman, Theodore R ^c   Taimi, Mohammed ^c   Emanuel, Peter D ^b   Zhang, Xiao Kun ^d   Chen, Guo Quan ^d   Sani, Brahma P ^e   Venepally, Pratap ^e   Reddy, Lakshmi ^e   Alam, Muzaffar ^a   Simpson Herren, Linda ^e   Hill, Donald L ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d BURNHAM INSTITUTE   (United States)

^e SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID DERIVATIVE;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CELL DIFFERENTIATION; DRUG CONFORMATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; LIGAND BINDING; MYELOMONOCYTIC LEUKEMIA; NONHUMAN; TRANSACTIVATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CHICKENS; CHILD; FATTY ACIDS, UNSATURATED; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LEUKEMIA, PROMYELOCYTIC, ACUTE; MICE; MOLECULAR CONFORMATION; NAPHTHALENES; PAPILLOMA; RADIOLIGAND ASSAY; RECEPTORS, RETINOIC ACID; SKIN; SKIN NEOPLASMS; STEREOISOMERISM; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR STEM CELL ASSAY;

EID: 15444345866     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970635h     Document Type: Article

References (39)

1. Rosen, J.; Day, A.; Jones, T. K.; Jones, E. T. T.; Nadzan, A. M.; Stein, R. B. Intracellular Receptors and Signal Transducers and Activators of Transcription Super-families: Novel Targets for Small-Molecule Drug Discovery. J. Med. Chem. 1995, 38, 4855-4874.
2. (a) Mangelsdorf, D. J.; Umesono, K.; Evans, R. M. The Retinoid Receptors. In THE RETINOIDS Biology, Chemistry and Medicine; 2nd ed.; Sporn, M. B., Roberts, A. B., Goodman, D. S., Eds.; Raven Press: New York, 1994; pp. 319-349.
3. (b) Gudas, L. Retinoids and Vertebrate Development. J. Biol. Chem. 1994, 269, 15399-15402.
4. Nadzan, A. M. Retinoids for the Treatment of Oncological Diseases. Annu. Rep. Med. Chem. 1995, 30, 119-128.
5. Degos, L.; Dombret, H.; Chomienne, C.; Daniel, M.-T.; Miclea, J.-M.; Chastang, C.; Castaigne, S.; Fenauz, P. AU-trans-Retinoic Acid as a Differentiating Agent in the Treatment of Acute Promyelocytic Leukemia. Blood 1995, 85, 2643-2653.
6. Castleberry, R. P.; Emanuel, P. D.; Zuckerman, K. S.; Cohn, S.; Strauss, L.; Byrd, R. L.; Homans, A.; Chaffee, S.; Nitschke, R.; Gualtieri, R. J. A Pilot Study of Isotrentinoin in the Treatment of Juvenile Chronic Myelogenous Leukemia, N. Engl. J. Med. 1994, 331, 1680-1684.
7. Emanuel, P. D.; Shannon, K. M.; Castleberry, R. P. Juvenile Myelomonocytic Leukemia: Molecular Understanding and Prospects for Therapy. Mol. Med. Today 1996, 2, 468-475.
8. Muccio, D. D.; Brouillette, W. J. (UAB Research Foundation) Retinoid Compounds. U.S. Patent 5,094,783, March 10, 1992.
9. Muccio, D. D.; Brouillette, W. J.; Alam, M.; Vaezi, M.; Sani, B. P.; Venepally, P.; Reddy, L.; Li, E.; Norris, A. W.; SimpsonHerren, L.; Hill, D. L. Conformationally Defined 6-s-transRetinoic Acid Analogues. 3. Structure-Activity Relationships for Nuclear Receptor Binding, Transcriptional Activity, and Cancer Chemoprevention. J. Med. Chem. 1996, 39, 3625-3635.
10. Alam, M.; Zhestkov, V.; Sani, B. P.; Venepally, P.; Levin, A. A.; Kazmer, S.; Li, E.; Norris, A. W.; Zhang, X.-k.; Lee, M. O.; Hill, D. L.; Lin, T.-H.; Brouillette, W. J.; Muccio, D. D. Conformationally Defined 6-s-trans-Retinoic Acid Analogues. 2. Selective Agonists for Nuclear Receptor Binding and Transcriptional Activity. J. Med. Chem. 1995, 38, 2303-2310.
11. Vaezi, M. F.; Alam, M.; Sani, B. P.; Rogers, T. S.; SimpsonHerren, L.; Wille, J. J.; Hill, D. L.; Doran, T. I.; Brouillette, W. J.; Muccio, D. D. A Conformationally Defined 6-s-frans-Retinoic Acid Isomer. Synthesis, Chemopreventive Activity, and Toxicity. J. Med. Chem. 1994, 37, 4499-4507.
12. 2-Retinal. Org. Prep. Proc. Int. 1987, 19, 187-195.
13. 3H Acetate. J. Labeled Compds. Radiopharm. 1977, 13, 123-135.
14. Zhang, X.-k.; Hoffmann, B.; Tran, P.; Graupner, G.; Pfahl, M. Retinoid X Receptor is an Auxiliary Protein for Thyroid Hormone and Retinoic Acid Receptors. Nature (London) 1992, 355, 441-446.
15. Verma, A.; Boutwell, R. Vitamin A Acid (Retinoic Acid), a Potent Inhibitor of 12-O-Tetradecanoylphorbol-13-acetate-induced Ornithine Decarboxylase Activity in Mouse Epidermis. Cancer Res. 1977, 37, 2196-2201.
16. (a) Breitman, T. R. Growth and Differentiation of Human Myeloid Leukemia Cell Line HL60. Methods Enzymol. 1990, 190, 118-130.
17. (b) Taimi, M.; Breitman, T. R. Growth, Differentiation, and Death of Retinoic Acid-Treated Human Acute Promyelocytic Leukemia NB4 Cells. Exp. Cell Res. 1997, 230, 69-75.
18. (a) Emanuel, P. D.; Bates, L. J.; Zhu, S.-W.; Castleberry, R. P.; Gualtieri, R. J.; Zuckerman, K. S. The Role of Monocyte-Derived Hemopoietic Growth Factors in the Regulation of Myeloproliferation in Juvenile Chronic Myelogemous Leukemia. Exp. Hematol. 1991, 19, 1017-1024.
19. (b) Emanuel, P. D.; Bates, L. J.; Zhu, S.-W.; Castleberry, R. P.; Gualtieri, R. J.; Zuckerman, K. Selective Hypersensitivity to Granulocyte-Macrophage ColonyStimulating Factor by Juvenile Chronic Myeloid Leukemia Hematopoietic Progenitors. Blood, 1991, 77, 925-929.
20. Lake, C. H.; Alam, M. A.; Muccio, D. D.; Brouillette, W. J. A Structural Model for a New Class of Conformationally Constrained Retinoid: (2Z,4E)-4-[3′, 4′-dihydro-l′(2′H) naphthalene1′-ylidene]-2-butenoic acid. J. Chem. Crystallogr. 1997, 27, 231-235.
21. (a) Sani, B. P.; Titus, B. C.; Banerjee, C. K. Determination of Binding Affinities of Retinoids to Retinoic Acid-Binding Protein and Serum Albumin. Biochem. J. 1978, 171, 711-717.
22. (b) Sani, B. P. Cellular Retinoic Acid-Binding Protein and the Action of Retinoic Acid. In Chemistry and Biology of Synthetic Retinoids; Dawson, M. I., Okamuar, W. H., Eds.; CRC Press: Boca Raton, FL, 1990; pp 365-384.
23. Graupner, G.; Wills, K. N.; Tzukerman, M.; Zhang, X.-k.; Pfahl, M. Dual Regulatory Role for Thyroid Hormone Receptors Allows Control of Retinoic Acid Receptor Activity. Nature (London) 1989, 340, 653-656.
24. (a) Chandraratna, R. A. S.; Gillett, S. J.; Song, T. K.; Attard, J.; Vuligonda, S.; Garst, M. E.; Arefieg, T.; Gil, D. W.; Wheeler, L. Synthesis and Pharmacological Activity of Conformationally Restricted, Acetylenic Retinoid Analogues. BioMed. Chem. Lett. 1995, 5, 523-527.
25. (b) Nagpal, S.; Athanikar, J.; Chandraratna, R. A. S. Separation of Transcription and API Antagonism Functions of Retinoic Acid Receptor a. J. Biol. Chem. 1995, 270, 923-927.
26. Castleberry, R. P.; Emanuel, P.; Gualtieri, R.; Zuckerman, K.; Cohn, S.; Strauss, L.; Byrd, R.; Romans, A.; Chaffee, S.; Nitshcke, R. Preliminary Experience with 13-Cis Retinoic Acid (CRA) in the Treatment of Juvenile Chronic Myelogenous Leukemia (JCML). Blood 1991, 78 (Suppl. 1), 170a.
27. (a) Lapidot, T.; Cohen, A.; Grunberger, T.; Dick, J.; Freedman, M. H. Aberrant Growth Properties of Juvenile Chronic Myelogenous Leukemia (JCML) CD34+ Cells in Vitro and in Vivo using SCID Mouse Assays, Blood 1993, 82 (Suppl. 1), 197a.
28. (b) Cambier, N.; Menot, M. L.; Fenaux, P.; Wattel, E.; Baruchel, A.; Chomienne, C. GM-CSF Hypersensitivity in CD34+ Purified Cells in Juvenile and Adult Chronic Myelomonocytic Leukemia: Effects of Retinoids. Blood 1995, 86 (Suppl 1), 791a.
29. Emanuel, P. D.; Sokol, J. M.; Castleberry, R. P. Characterization of Early Response Gene Expression in Juvenile Myelomonocytic Leukemia Syndrome (JMML). Blood 1995, 86 (Suppl 1), 728a.
30. (a) Yang Yen, H.-F.; Zhang, X.-K.; Graupner, G.; Tzukerman, M.; Sakamoto, B.; Karin, M.; Pfahl, M. Antagonism between Retinoic Acid Receptors and AP-1: Implications for Tumor Promotion and Inflammation. New Biol. 1991, 3, 1206-1219.
31. (b) Schule, R.; Rangarajan, P.; Yang, N.; Kliewer, S.; Ransone, L. J.; Bolado, J.; Verma, I. M.; Evans, R. M. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 6092-6096.
32. (c) Pfahl, M. Nuclear Receptor/ AP-1 Interactions. Endocrine Rev. 1993, 14, 651-658.
33. Salbert, G.; Fanjul, A.; Piedrafita, F. J.; Lu, X. P.; Kim, S.-J.; Tran, P.; Pfahl, M. Retinoic Acid Receptors and Retinoid X Receptor-α Down-Regulate the Transforming Growth Factor-β1 Promoter by Antagonizing AP-1 Activity. Mol. Endocrinol. 1993, 7, 1347-1356.
34. (a) Fanjul, A.; Dawson, M. I.; Hobbs, P. D.; Jong, L.; Cameron, J. F.; Harlev, E.; Graupner, G.; Lu, X.-P.; Pfahl, M. A New Class of Retinoids with Selective Inhibition of AP-1 Inhibits Proliferation. Nature 1994, 372, 107-111.
35. (b) Nagpal, S.; Athanikar, J.; Chandraratna, R. A. S. Separation of Transactivation and API Antagonism Functions of Retinoic Acid Receptor α. J. Biol. Chem. 1995, 270, 923-927.
36. (a) Kizaki, M.; Nakajima, H.; Mori, S.; Koike, T.; Morikawa, M.; Ohta, M.; Saito, M.; Koeffler, H. R.; Ikeda, Y. Novel Retinoic acid, 9-Cis Retinoic Acid, in Combination with All-Trans Retinoic Acid Is an Effective Inducer of Differentiation of Retinoic AcidResistance HL-60 Cells. Blood 1994, 83, 3289-3297.
37. (b) Kizaki, M.; Dawson, M. I.; Heyman, R.; Eistner, E.; Morosetti, R.; Pakkala, S.; Chen, D.-L.; Ueno, H.; Chao, W.-r.; Morikawa, M.; Ikeda, Y.; Heber, D.; Pfahl, M.; Koeffler, H. R. Effects of Novel Retinoid X Receptor-Selective Ligands on Myeloid Leukemia Differentiation and Proliferation in Vitro. Blood 1996, 87, 1977-1984.
38. Chen, J.-Y.; Clifford, J.; Zusi, C.; Starrett, J.; Tortolani, D.; Ostrowski, J.; Reczek, P. R.; Chambon, P.; Gronemeyer, H. Two Distinct Actions of Retinoid-Receptor Ligands, Nature 1996, 382, 819-822.
39. Lin, T.-H.; Rogers, T. S.; Hill, D. H.; Simpson-Herren, L.; Farnell, D. R.; Kochhar, D. M.; Alam, M.; Brouillette, W. J.; Muccio, D. D. Murine Toxicology and Pharmacology of UAB-8, a Confor- mationally Constrained Analogue of Retinoic Acid. Toxicol. Appl. Pharmacol. 1996, 139, 310-316.